Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| January 23, 2024 | 3.141B |
| January 22, 2024 | 3.141B |
| January 19, 2024 | 3.148B |
| January 18, 2024 | 3.150B |
| January 17, 2024 | 3.153B |
| January 16, 2024 | 3.161B |
| January 12, 2024 | 3.182B |
| January 11, 2024 | 3.155B |
| January 10, 2024 | 3.155B |
| January 09, 2024 | 3.165B |
| January 08, 2024 | 3.169B |
| January 05, 2024 | 3.169B |
| January 04, 2024 | 3.157B |
| January 03, 2024 | 3.155B |
| January 02, 2024 | 3.170B |
| December 29, 2023 | 3.145B |
| December 28, 2023 | 3.156B |
| December 27, 2023 | 3.155B |
| December 26, 2023 | 3.162B |
| December 22, 2023 | 3.158B |
| December 21, 2023 | 3.161B |
| December 20, 2023 | 3.159B |
| December 19, 2023 | 3.147B |
| December 18, 2023 | 3.078B |
| December 15, 2023 | 3.077B |
| Date | Value |
|---|---|
| December 14, 2023 | 3.048B |
| December 13, 2023 | 3.048B |
| December 12, 2023 | 3.008B |
| December 11, 2023 | 2.992B |
| December 08, 2023 | 2.986B |
| December 07, 2023 | 3.000B |
| December 06, 2023 | 2.997B |
| December 05, 2023 | 3.002B |
| December 04, 2023 | 3.018B |
| December 01, 2023 | 3.028B |
| November 30, 2023 | 3.004B |
| November 29, 2023 | 3.019B |
| November 28, 2023 | 3.011B |
| November 27, 2023 | 2.999B |
| November 24, 2023 | 3.008B |
| November 22, 2023 | 3.013B |
| November 21, 2023 | 2.985B |
| November 20, 2023 | 2.987B |
| November 17, 2023 | 2.990B |
| November 16, 2023 | 2.978B |
| November 15, 2023 | 2.967B |
| November 14, 2023 | 2.985B |
| November 13, 2023 | 2.970B |
| November 10, 2023 | 2.972B |
| November 09, 2023 | 2.936B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
847.96M
Minimum
May 31 2022
11.50B
Maximum
Dec 10 2020
4.440B
Average
3.462B
Median
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 160.36B |
| Karuna Therapeutics Inc (DELISTED) | 11.34B |
| Puma Biotechnology Inc | 128.12M |
| NovaBay Pharmaceuticals Inc | 2.833M |
| Palatin Technologies Inc | 11.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -161.90M |
| Revenue (Quarterly) | 16.40M |
| Total Expenses (Quarterly) | 188.45M |
| EPS Diluted (Quarterly) | -2.49 |
| Gross Profit Margin (Quarterly) | 89.71% |
| Profit Margin (Quarterly) | -987.2% |